DOH halts use of HIV drug combination for hospitalized COVID-19 patients

Tuesday, July 7th, 2020. Filed under: Health & Fitness News World News

MANILA, July 6 (Mabuhay) — The Department of Health said Sunday it would stop the use of combination HIV drug lopinavir and ritonavir in its treatment of hospitalized COVID-19 patients following the World Health Organization’s move.

The agency had also previously discontinued using anti-malaria drug hydroxychloroquine, according to Health Undersecretary Maria Rosario Vergeire.

“Based on the recent evidence and recommendations from our experts, we will be stopping the use of lopinavir and ritonavir among hospitalized patients,” she told reporters.

Patients who have started using lopinavir and ritonavir may complete the whole course of the treatment, or opt to discontinue, Vergeire said.

The UN agency said the decision, taken on the recommendation of the trial’s international steering committee, does not affect other studies where those drugs are used for non-hospitalized patients or as a prophylaxis.

The solidarity trial began in March with possible treatment approaches to COVID-19 using remdesivir, hydroxychloroquine, lopinavir/ritonavir, and lopanivir/ritonavir combined with interferon.

Vergeire said that with the removal of the lopinavir/ritonavir and hydroxychloroquine from the trials, “we will have remdesivir plus interferon as the new regimen… and standard of care, once shipment of interferon arrives.”

The Philippines on Saturday reported its second largest spike of 1,494 new confirmed COVID-19 cases, raising its total to 41,830. Of this figure, the country tallied 11,453 recoveries and 1,290 deaths. (MNS)

ALSO READ: Steam inhalation may trigger COVID-19 spread – DOH exec

Related posts

DOST expects VCO trial results will be released 2nd week of NovemberPalace assures Covid-19 vaccine’s affordability‘Vaccine hesitancy’ has dropped in Philippines, says DuquePRRD ‘most hopeful’ about potential China-made vaccineAvigan trial still awaiting finalization of legal documents –DOHCOVID-19 vaccine may be available in Philippines 2nd quarter of 2021 — DOHDuterte prefers Russia, China’s COVID-19 vaccines as other firms ask for advance payment1.5K Pinoys in UAE join Sinopharm’s vaccine clinical trialsDOH hopes to start Avigan trial in coming weeksRussia says Philippines may manufacture anti-COVID-19 vaccine Sputnik VDelay hits start of Avigan clinical trials in PhilippinesLagundi clinical trials get FDA nod — DOST chiefAvigan trials in PH still hasn’t started — DOHPH in talks with at least 16 COVID-19 vaccine developers – DOHSputnik V availability in Philippines seen by April 2021Beijing welcomes FDA approval of Chinese traditional medicineDOST to lead clinical trials for Covid-19 vaccine from RussiaPRRD accepts Russia’s CoVid-19 vaccine offerDuterte’s dilemma: After Russian vaccine, can I get COVID-19 shots from other countries?DOH earmarks initial P2.4 billion for purchase of vaccine vs. COVID-19